Table 1. Demographic variables and comorbidities .
*Gout and systemic lupous erythematosus
CVA: cerebrovascular disease; LV: left ventricular; SD: standard deviation
| Perioperative recipient factors | Requirement of postoperative dialysis | P-value | |
| No, n (%) | Yes, n (%) | ||
| Gender | 0.671 | ||
| Female | 26 (28.0) | 1 (14.3) | |
| Male | 67 (72.0) | 6 (85.7) | |
| Type of graft | 0.120 | ||
| Live | 86 (92.5) | 5 (71.4) | |
| Deceased | 7 (7.5) | 2 (28.6) | |
| Hypertension | 1.000 | ||
| No | 5 (5.4) | ||
| Yes | 88 (94.6) | 7 (100.0) | |
| Diabetes mellitus | 0.023 | ||
| No | 78 (83.9) | 3 (42.9) | |
| Yes | 15 (16.1) | 4 (57.1) | |
| Dyslipidemia | 0.021 | ||
| No | 86 (92.5) | 4 (57.1) | |
| Yes | 7 (7.5) | 3 (42.9) | |
| Hypothyroidism | 1.000 | ||
| No | 82 (88.2) | 7 (100.0) | |
| Yes | 11 (11.8) | ||
| Coronary artery disease | 0.093 | ||
| No | 79 (84.9) | 4 (57.1) | |
| Yes | 14 (15.1) | 3 (42.9) | |
| Valvular heart disease | |||
| No | 89 (97.8) | 7 (100.0) | 1.000 |
| Yes | 2 (2.2) | ||
| LV dysfunction | 0.096 | ||
| No | 87 (93.5) | 5 (71.4) | |
| Yes | 6 (6.5) | 2 (28.6) | |
| Cardiomyopathies | 1.000 | ||
| No | 89 (97.8) | 7 (100.0) | |
| Yes | 2 (2.2) | ||
| Others* | 0.664 | ||
| No | 64 (68.8) | 5 (83.3) | |
| Yes | 29 (31.2) | 1 (16.7) | |
| CVA | 7 (100.0) | 1.000 | |
| No | 90 (96.8) | ||
| Yes | 3 (3.2) | ||
| Use of basiliximab | 0.112 | ||
| No | 58 (62.4%) | 2 (28.6%) | |
| Yes | 35 (37.6%) | 5 (71.4) | |